CASP9 and ovarian cancer: We further demonstrated that (−)-asarinin (1) stimulated the activation of caspase-3, caspase-8, and caspase-9, and caspase inhibitors significantly reversed (−)-asarinin (1)-induced cell death in human ovarian cancer cells.